# FDA Inspection 702469 - University of Maryland Medical Center Midtown Campus - December 17, 2010

Source: https://www.keypedia.com/records/fda_inspections/university-of-maryland-medical-center-midtown-campus/b08519ab-874d-4cf8-bfab-0f9c06d73960
Source feed: FDA_Inspections

> FDA Inspection 702469 for University of Maryland Medical Center Midtown Campus on December 17, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 702469
- Company Name: University of Maryland Medical Center Midtown Campus
- Inspection Date: 2010-12-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1082606 - 2019-03-01](https://www.keypedia.com/records/fda_inspections/university-of-maryland-medical-center-midtown-campus/eec5567a-affd-4824-9e21-e45e3ddfed77)
- [FDA Inspection 964815 - 2016-03-10](https://www.keypedia.com/records/fda_inspections/university-of-maryland-medical-center-midtown-campus/6f850d66-a5a8-4603-a322-46a548f5c780)
- [FDA Inspection 864738 - 2014-01-29](https://www.keypedia.com/records/fda_inspections/university-of-maryland-medical-center-midtown-campus/56e3e980-874d-44e9-bb44-f8121c7e3e22)

Company: https://www.keypedia.com/companies/university-of-maryland-medical-center-midtown-campus/d01c469b-4fb3-4a25-9382-503d53e765f8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d